An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy

Niamh Keane; P Price; Silvia Lee; Shelley Stone; MA French

doi:10.1046/j.1365-2249.2001.01647.x

An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy

Niamh Keane, P Price, Silvia Lee, Shelley Stone, MA French

Research output: Contribution to journal › Article › peer-review

40 Citations (Web of Science)

Original language	English
Pages (from-to)	111-116
Number of pages	6
Journal	Clinical and Experimental Immunology
Volume	126
Issue number	1
DOIs	https://doi.org/10.1046/j.1365-2249.2001.01647.x
Publication status	Published - Oct 2001

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1046/j.1365-2249.2001.01647.x

Cite this

@article{33d5dea9fba2449eaf53290fc11e4ad3,

title = "An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy",

keywords = "CD26 (DPPIV), CD30, HIV, Interferon-gamma",

author = "Niamh Keane and P Price and Silvia Lee and Shelley Stone and MA French",

year = "2001",

month = oct,

doi = "10.1046/j.1365-2249.2001.01647.x",

language = "English",

volume = "126",

pages = "111--116",

journal = "Clinical and Experimental Immunology",

issn = "0009-9104",

publisher = "Wiley-Blackwell",

number = "1",

}

An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy. / Keane, Niamh; Price, P; Lee, Silvia et al.
In: Clinical and Experimental Immunology, Vol. 126, No. 1, 10.2001, p. 111-116.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy

AU - Keane, Niamh

AU - Price, P

AU - Lee, Silvia

AU - Stone, Shelley

AU - French, MA

PY - 2001/10

Y1 - 2001/10

KW - CD26 (DPPIV)

KW - CD30

KW - HIV

KW - Interferon-gamma

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=uwapure5-25&SrcAuth=WosAPI&KeyUT=WOS:000171749200015&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1046/j.1365-2249.2001.01647.x

DO - 10.1046/j.1365-2249.2001.01647.x

M3 - Article

C2 - 11678906

SN - 0009-9104

VL - 126

SP - 111

EP - 116

JO - Clinical and Experimental Immunology

JF - Clinical and Experimental Immunology

IS - 1

ER -

An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy

UN SDGs

Access to Document

Other files and links

Cite this